Keyphrases
Neoantigen
73%
DNA Vaccine
63%
Coccidioidomycosis
57%
CD8+ T Cells
48%
Neoantigen Vaccine
47%
Cancer Neoantigens
46%
Cellular Immune Response
37%
Vaccine Platform
32%
Single-chain Trimer
32%
Tumor Immunity
31%
Specific Immune Response
30%
Clinical Development
29%
Cellular Immunity
28%
Pancreatic Cancer
28%
Mammaglobin
28%
Breast Cancer
25%
CD8+ T
22%
Vaccination
22%
Antigen Preparation
21%
Pancreatic Ductal Adenocarcinoma
21%
Tumor
21%
Immune Response
21%
Epitope
20%
Interferon-γ
20%
Clinical Translation
20%
Antigen Processing
19%
T Cells
19%
HLA-A2
18%
Dendritic Cells
18%
Cell Response
17%
MHC Class I
17%
Whole Blood
17%
Interleukin-10
17%
CD69
17%
CD8+
17%
Clinical Assessment
15%
Breast Cancer Patients
15%
Personalized Cancer Therapy
15%
Genome Sequencing
15%
Antigen Presentation
14%
PD-1 Blockade
14%
TIGIT
14%
Lymphocyte Cell
14%
Immune Suppressor
14%
Granuloma
14%
Mannose Receptor
14%
Interferon-α (IFN-α)
14%
Cell Clusters
14%
Fluorescence Intensity
14%
Whole Blood Analysis
14%
Immunology and Microbiology
Neoantigen
100%
Cytotoxic T-Cell
82%
DNA Immunization
63%
Adoptive Immunity
60%
Immune Response
51%
Peptides
37%
Dendritic Cell
32%
Antigen Presentation
32%
Epitope
32%
T Cell
27%
CD8
24%
MHC Class I
22%
Interferon Gamma
19%
Viral Disease
17%
Immunotherapy
17%
CD69
16%
Tumor Vaccine
16%
Interleukin 10
16%
Lymphocyte
16%
Immunology
15%
Genome Sequencing
14%
interferon
14%
Mannose Receptor
14%
Granuloma
14%
Biological Product
14%
T-Helper Cell
14%
Tumor Immunity
14%
West Nile Virus
14%
Adenovirus Vector
14%
Interleukin 2
11%
CD4
10%
Progression Free Survival
9%
Single-Domain Antibody
9%
Tumor Antigen
9%
Cross-Presentation
8%
B Cell
8%
Immune System
7%
Cytotoxic T Cell
7%
ELISPOT
7%
Tumor Rejection
6%
Cancer Immunotherapy
5%
Xenograft
5%
Cell Line
5%